MASTER SERVICES AGREEMENTMaster Services Agreement • March 29th, 2005 • Corcept Therapeutics Inc • Pharmaceutical preparations • England and Wales
THIS Master Services Agreement (the “Agreement”) is effective as of the 28th day of October, 2004, (the “Effective Date”), by and between i3 Research, a division of Ingenix Pharmaceutical Services (UK) Limited. (“Ingenix”), with offices at Sygnus Court, 22-32 Market Street, Maidenhead, Berkshire, UK SL6 8AD, and Corcept Therapeutics Incorporated (“Sponsor”), with offices at 275 Middlefield Road, Suite A, Menlo Park, CA 94025.
